Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Degenerative changes and immune response after transcatheter aortic valve implantation. Comparison with surgical aortic valve replacement.

Sulženko J, Toušek P, Kočka V, Bednář F, Línková H, Petr R, Laboš M, Widimský P.

J Cardiol. 2016 Apr 22. pii: S0914-5087(16)30028-4. doi: 10.1016/j.jjcc.2016.03.009. [Epub ahead of print]

PMID:
27117541
2.

ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Ortega-Paz L, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Giacchi G, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M.

Int J Cardiol. 2016 Apr 7;214:483-484. doi: 10.1016/j.ijcard.2016.04.016. [Epub ahead of print] No abstract available.

PMID:
27096965
3.

Bioresorbable vascular scaffolds in STEMI patients: multimodality imaging comparison in mid-term perspective.

Marchese G, Petr R, Tousek P, Widimsky P, Kocka V.

Minerva Cardioangiol. 2016 Apr 12. [Epub ahead of print]

PMID:
27070202
4.

Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study.

Toušek P, Kočka V, Malý M, Kozel M, Robert P, Hajšl M, Jarkovský J, Widimský P.

Int J Cardiol. 2016 Apr 15;209:20-1. doi: 10.1016/j.ijcard.2016.02.029. Epub 2016 Feb 3. No abstract available.

PMID:
26878467
5.

Manual aspiration thrombectomy devices use in coronary interventions in 2016.

Kočka V, Toušek P.

Expert Rev Med Devices. 2016 Mar;13(3):243-51. doi: 10.1586/17434440.2016.1146586. Epub 2016 Feb 20.

PMID:
26808609
6.

Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.

Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J Jr.

Hypertension. 2016 Feb;67(2):397-403. doi: 10.1161/HYPERTENSIONAHA.115.06526. Epub 2015 Dec 22.

PMID:
26693818
7.

One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study.

Widimsky P, Petr R, Tousek P, Maly M, Linkova H, Vrana J, Hajsl M, Budesinsky T, Lisa L, Kocka V.

Circ Cardiovasc Interv. 2015 Dec;8(12):e002933. doi: 10.1161/CIRCINTERVENTIONS.115.002933.

PMID:
26628591
8.

Absorb bioresorbable stents for the treatment of coronary artery disease.

Kočka V, Toušek P, Widimský P.

Expert Rev Med Devices. 2015;12(5):545-57. doi: 10.1586/17434440.2015.1080119.

PMID:
26305838
9.

Transcatheter aortic valve implantation: long-term clinical outcome and valve durability.

Sulzenko J, Tousek P, Kocka V, Widimsky P.

Expert Rev Med Devices. 2015;12(5):529-35. doi: 10.1586/17434440.2015.1063994. Epub 2015 Jul 3.

PMID:
26134100
10.

Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.

Toušek P, Kočka V, Malý M, Lisa L, Buděšínský T, Widimský P.

Heart Vessels. 2015 Apr 21. [Epub ahead of print]

PMID:
25896128
11.

Potential role of invariant natural killer T cells in outcomes of acute myocardial infarction.

Novak J, Dobrovolny J, Tousek P, Kocka V, Teringova E, Novakova L, Widimsky P.

Int J Cardiol. 2015;187:663-5. doi: 10.1016/j.ijcard.2015.03.398. Epub 2015 Mar 28. No abstract available.

PMID:
25880406
12.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-97. doi: 10.1016/j.jcin.2014.10.005. Erratum in: JACC Cardiovasc Interv. 2015 Mar;8(3):503.

13.

Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.

Rosa J, Widimský P, Toušek P, Petrák O, Čurila K, Waldauf P, Bednář F, Zelinka T, Holaj R, Štrauch B, Šomlóová Z, Táborský M, Václavík J, Kociánová E, Branny M, Nykl I, Jiravský O, Widimský J Jr.

Hypertension. 2015 Feb;65(2):407-13. doi: 10.1161/HYPERTENSIONAHA.114.04019. Epub 2014 Nov 24.

14.

[Fully absorbable drug eluting coronary stent: where do we stand in 2014?].

Kočka V, Toušek P, Lisa L, Buděšínský T.

Vnitr Lek. 2014 Apr;60(4):322-6. Review. Czech.

PMID:
24985992
15.

Eligibility for renal denervation: experience at 11 European expert centers.

Persu A, Jin Y, Baelen M, Vink E, Verloop WL, Schmidt B, Blicher MK, Severino F, Wuerzner G, Taylor A, Pechère-Bertschi A, Jokhaji F, Fadl Elmula FE, Rosa J, Czarnecka D, Ehret G, Kahan T, Renkin J, Widimsky J Jr, Jacobs L, Spiering W, Burnier M, Mark PB, Menne J, Olsen MH, Blankestijn PJ, Kjeldsen S, Bots ML, Staessen JA; European Network Coordinating research on REnal Denervation Consortium.

Hypertension. 2014 Jun;63(6):1319-25. doi: 10.1161/HYPERTENSIONAHA.114.03194. Epub 2014 Mar 24.

16.

The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry.

Tousek P, Tousek F, Horak D, Cervinka P, Rokyta R, Pesl L, Jarkovsky J, Widimsky P; CZECH-2 Investigators.

Int J Cardiol. 2014 May 1;173(2):204-8. doi: 10.1016/j.ijcard.2014.02.013. Epub 2014 Feb 22.

17.

Infective endocarditis as a mid-term complication after transcatheter aortic valve implantation: case report and literature review.

Sulženko J, Toušek P, Línková H.

Catheter Cardiovasc Interv. 2014 Aug 1;84(2):311-5. doi: 10.1002/ccd.25454. Epub 2014 Mar 4. Review.

PMID:
24550078
18.

Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?

Rosa J, Zelinka T, Petrák O, Štrauch B, Šomlóová Z, Indra T, Holaj R, Čurila K, Toušek P, Šenitko M, Widimský P, Widimský J Jr.

J Hum Hypertens. 2014 Nov;28(11):684-8. doi: 10.1038/jhh.2014.3. Epub 2014 Feb 6.

PMID:
24500722
19.

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'.

Kočka V, Malý M, Toušek P, Buděšínský T, Lisa L, Prodanov P, Jarkovský J, Widimský P.

Eur Heart J. 2014 Mar;35(12):787-94. doi: 10.1093/eurheartj/eht545. Epub 2014 Jan 12.

20.

Pharmacodynamic effect of clopidogrel in patients undergoing transcatheter aortic valve implantation.

Tousek P, Kocka V, Sulzenko J, Bednar F, Linkova H, Widimsky P.

Biomed Res Int. 2013;2013:386074. doi: 10.1155/2013/386074. Epub 2013 Jul 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk